Back to results
US 2014/0228284 A1Published application
Pharmaceutical compositions
AssigneeGlaxoSmithKline LLC
InventorsMark A. BUSH, Murray W. Stewart, Yonghong Yang
Life of this patent
Estimating the term…
Abstract
The present invention provides pharmaceutical compositions comprising at least one polypeptide having GLP-1 activity wherein an effective dose of said pharmaceutical composition comprises 15 mg, 30 mg, 50 mg or 100 mg of said polypeptide having GLP-1 activity. Also provided are methods of administering the pharmaceutical compositions of the invention.
Claims12
A method of treating diabetes in a human comprising administering to said human a an initial dose of a pharmaceutical composition comprising about 30 mg of a polypeptide comprising the amino acid sequence set forth in SEQ ID NO:1.
Dependencies are inferred from the claim text.